Amgen’s cancer-drug pipeline looks promising despite FDA setback, analysts say
October 11, 2023 at 08:47 AM EDT
Strong oncology, obesity, and cardiovascular drug candidates behind rating upgrade
Workboat Indexes
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
